newsfilter
← Latest News
GlobeNewswire·

Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update

GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment